Wednesday
SESSION 34: IMPORTANT ISSUES FOR VASCULAR SURGEONS AND SPECIALISTS; REMEMBRANCES; ASSET PROTECTION; KEY MEDICAL, HISTORICAL AND ETHICAL TOPICS
SESSION 34 SCHEDULE
10:16 AM - 10:21 AM Giants No Longer With Us: A Tribute To Allan Callow, Calvin Ernst And John (Jack) Connolly
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
  View Slides in PDF      
10:22 AM - 10:27 AM Predictions For The Future In The Treatment Of Vascular Disease: Where Is Vascular Surgery Going
  Presenter(s):Mark A. Adelman, MD  
  View Slides in PDF      
10:28 AM - 10:33 AM Negotiating With Large Health Care Systems: Tips And Tricks For Individual Vascular Surgeons: How Could A Union Or Society Help
  Presenter(s):Timothy M. Sullivan, MD  
  View Slides in PDF      
10:34 AM - 10:39 AM Beyond Vascular Surgery For Vascular Surgeons: Working With Industry: What Is Good About It And What Is Bad
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
10:40 AM - 10:45 AM Why Vascular Surgeons Are An Essential Operating Room Resource For Other Surgeons: They Must Be Valued As Such, Protected And Compensated
  Presenter(s):Gregory L. Moneta, MD  
  View Slides in PDF      
10:46 AM - 10:51 AM Is It A Wild West Bonanza Or A Feeding Frenzy: How To Stem The Surge In Unnecessary Lower Extremity Interventions That Cost So Much And Do Little To Benefit Patients
  Presenter(s):Scott L. Stevens, MD  
  View Slides in PDF      
10:52 AM - 10:57 AM Key Points In Asset Protection, Tax Planning And Succession Planning For Vascular Surgeons/Specialists
  Presenter(s):Hillel Presser, Esq., MBA  
  View Slides in PDF      
10:58 AM - 11:04 AM Panel Discussion
KEY NON-SURGICAL ISSUES
Moderator(s): Michael L. Marin, MD / Frank J. Veith, MD  
11:04 AM - 11:09 AM Optimal Treatment For Left Main Coronary Lesion Is Changing: Stenting With DESs Is Replacing Open Coronary Bypass: Based On The EXCEL Trial
  Presenter(s):Gregg W. Stone, MD  
  View Slides in PDF      
11:10 AM - 11:15 AM COURAGE Trial Findings After 15 Years Follow-Up: It Still Shows No Advantage Over Medical Treatment In Some Coronary Disease Patients: Are Too Many Patients Getting Coronary Stents
  Presenter(s):Roxana Mehran, MD  
  View Slides in PDF      
11:16 AM - 11:21 AM Role Of Stents In The Treatment Of Lower Extremity Occlusive Lesions: Value Of DESs And DCBs: Will Bare Metal Stent Usage Decrease Or Disappear
  Presenter(s):John H. Rundback, MD, FSIR, FAHA  
  View Slides in PDF      
11:22 AM - 11:27 AM Current Status Of Cell And Gene Therapy For CLI Treatment: Do Either Have A Future
  Presenter(s):Sigrid Nikol, MD  
  View Slides in PDF      
11:28 AM - 11:33 AM Long-Term Results Of Autologous Bone Marrow Cell Treatment For No Option CLI: Results Of A Double Blinded RCT
  Presenter(s):Thomas F. O'Donnell, Jr., MD / Mark D. Iafrati, MD  
  View Slides in PDF      
AN HISTORICAL NOTE
11:34 AM - 11:39 AM What Are “Octopus” Endografts: Why Are They The Future Of Branched Endografting For TAAAs And What Is Their Origin
  Presenter(s):Karthikeshwar Kasirajan, MD  
  View Slides in PDF      
ETHICAL ISSUES
11:40 AM - 11:45 AM Ethical Conflicts In Providing Quality Care With All The Financial And RVU Pressures In The Current Health Care System: How To Resolve Them
  Presenter(s):James W. Jones, MD, PhD, MHA  
  View Slides in PDF      
11:46 AM - 11:51 AM How To Involve Vascular Patients In Decision Making About Their Surgical And Interventional Treatments
  Presenter(s):Dirk T. Ubbink, MD, PhD  
  View Slides in PDF      
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 34
previous next